Similar articles

• Drug resistance to 5-aza-2'-deoxycytidine, 2',2'-difluorodeoxycytidine, and cytosine arabinoside conferred by retroviral-mediated transfer of human cytidine deaminase cDNA into murine cells.

  Eliopoulos N, Cournoyer D, Momparler RL. Eliopoulos N, et al. Cancer Chemother Pharmacol. 1998;42(5):373-8. doi: 10.1007/s002800050832. Cancer Chemother Pharmacol. 1998. PMID: 9771951
• Selection of drug-resistant transduced cells with cytosine nucleoside analogs using the human cytidine deaminase gene.

  Beauséjour CM, Eliopoulos N, Momparler L, Le NL, Momparler RL. Beauséjour CM, et al. Cancer Gene Ther. 2001 Sep;8(9):669-76. doi: 10.1038/sj.cgt.7700358. Cancer Gene Ther. 2001. PMID: 11593336
• Forced expression of cytidine deaminase confers resistance to cytosine arabinoside and gemcitabine.

  Neff T, Blau CA. Neff T, et al. Exp Hematol. 1996 Sep;24(11):1340-6. Exp Hematol. 1996. PMID: 8862446
• Pharmacological approach for optimization of the dose schedule of 5-Aza-2'-deoxycytidine (Decitabine) for the therapy of leukemia.

  Momparler RL, Côté S, Eliopoulos N. Momparler RL, et al. Leukemia. 1997 Feb;11(2):175-80. doi: 10.1038/sj.leu.2400550. Leukemia. 1997. PMID: 9009076 Review.
• [Prediction of adverse drug reactions based on genomic information].

  Sawada J, Saito Y. Sawada J, et al. Nihon Rinsho. 2007 Oct 28;65 Suppl 8:16-21. Nihon Rinsho. 2007. PMID: 18074510 Review. Japanese. No abstract available.